361 related articles for article (PubMed ID: 32973674)
1. The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.
Zheng MH; Li FX; Xu F; Lin X; Wang Y; Xu QS; Guo B; Yuan LQ
Front Endocrinol (Lausanne); 2020; 11():539. PubMed ID: 32973674
[TBL] [Abstract][Full Text] [Related]
2. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.
Brown JM; Vaidya A
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):193-201. PubMed ID: 24694551
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism].
Dobreva EA; Bibik EE; Eremkina AK; Ajnetdinova AR; Nikankina LV; Malysheva NM; Mokrysheva NG
Ter Arkh; 2020 Nov; 92(10):63-69. PubMed ID: 33346481
[TBL] [Abstract][Full Text] [Related]
4. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Brown JM; Williams JS; Luther JM; Garg R; Garza AE; Pojoga LH; Ruan DT; Williams GH; Adler GK; Vaidya A
Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension.
Castellano E; Pellegrino M; Tardivo V; Attanasio R; Boriano A; Borretta G
Endocr Pract; 2021 Nov; 27(11):1072-1076. PubMed ID: 33965584
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
Brown J; de Boer IH; Robinson-Cohen C; Siscovick DS; Kestenbaum B; Allison M; Vaidya A
J Clin Endocrinol Metab; 2015 Feb; 100(2):490-9. PubMed ID: 25412416
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Fahrleitner-Pammer A; Kienreich K; Horina JH; Drechsler C; März W; Ofner M; Pieber TR; Pilz S
Cardiovasc Res; 2012 Apr; 94(1):10-9. PubMed ID: 22334595
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
Latic N; Erben RG
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin-aldosterone system and calcium-regulatory hormones.
Vaidya A; Brown JM; Williams JS
J Hum Hypertens; 2015 Sep; 29(9):515-21. PubMed ID: 25631218
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
Bislev LS; Langagergaard Rødbro L; Nørgaard Bech J; Bjerregaard Pedersen E; Rolighed L; Sikjaer T; Rejnmark L
Clin Endocrinol (Oxf); 2018 Nov; 89(5):656-666. PubMed ID: 29733445
[TBL] [Abstract][Full Text] [Related]
12. Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.
Kono K; Fujii H; Watanabe K; Goto S; Nishi S
J Bone Miner Metab; 2021 Mar; 39(2):230-236. PubMed ID: 32920706
[TBL] [Abstract][Full Text] [Related]
13. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.
Bernini G; Moretti A; Lonzi S; Bendinelli C; Miccoli P; Salvetti A
Metabolism; 1999 Mar; 48(3):298-300. PubMed ID: 10094103
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
17. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Gland Function in Primary Aldosteronism.
Asbach E; Bekeran M; Reincke M
Horm Metab Res; 2015 Dec; 47(13):994-9. PubMed ID: 26667802
[TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.
Bislev LS; Langagergaard Rødbro L; Bech JN; Pedersen EB; Kjaergaard AD; Ladefoged SA; Rolighed L; Sikjaer T; Rejnmark L
Endocrine; 2018 Oct; 62(1):182-194. PubMed ID: 30043092
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
Pilz S; Kienreich K; Drechsler C; Ritz E; Fahrleitner-Pammer A; Gaksch M; Meinitzer A; März W; Pieber TR; Tomaschitz A
J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
